Related Experiment Video
Updated: Aug 29, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Cyclin D1 expression and cell cycle response in DNA mismatch repair-deficient cells upon methylation and UV-C damage
Anne Lützen1, Hanne Cathrine Bisgaard, Lene Juel Rasmussen
1Department of Life Sciences and Chemistry, Roskilde University, 4000 Roskilde, Denmark.
Abstract:
We have evaluated cell survival, apoptosis, and cell cycle responses in a panel of DNA mismatch repair (MMR)-deficient colon and prostate cancer cell lines after alkylation and UV-C damage. We show that although these MMR-deficient cells tolerate alkylation damage, they are as sensitive to UV-C-induced damage as are the MMR-proficient cells. MMR-proficient cells arrest in the S-G2 phase of the cell cycle and initiate apoptosis following alkylation damage, whereas MMR-deficient cells continue proliferation. However, two prostate cancer cell lines that are MMR-deficient surprisingly arrest transiently in S-G2 after alkylation damage. Progression through G1 phase initially depends on the expression of one or more of the D-type cyclins (D1, D2, and/or D3). Analysis of cyclin D1 expression shows an initial MMR-independent decrease in the protein level after alkylation as well as UV-C damage. At later time points, however, only DNA damage-arrested cells showed decreased cyclin D1 levels irrespective of MMR status, indicating that reduced cyclin D1 could be a result of a smaller fraction of cells being in G1 phase rather than a result of an intact MMR system. Finally, we show that cyclin D1 is degraded by the proteasome in response to alkylation damage.
Insights
DNA mismatch repair (MMR)-deficient cells tolerate alkylation damage but are sensitive to UV-C damage. Cyclin D1 degradation by the proteasome occurs in response to alkylation, regardless of MMR status.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- DNA mismatch repair (MMR) is crucial for genomic stability.
- MMR deficiency impacts cellular responses to DNA damage.
- Cancer cells often exhibit MMR deficiency.
Purpose of the Study:
- To investigate the differential responses of MMR-deficient cancer cells to alkylation and UV-C DNA damage.
- To elucidate the role of cell cycle regulators, specifically cyclin D1, in these responses.
- To determine the mechanisms of cyclin D1 regulation following DNA damage in MMR-proficient and MMR-deficient cells.
Main Methods:
- Culturing and treating MMR-deficient and MMR-proficient colon and prostate cancer cell lines.
- Assessing cell survival, apoptosis, and cell cycle progression.
- Analyzing cyclin D1 protein levels and degradation pathways (proteasome).
Main Results:
- MMR-deficient cells tolerated alkylation damage but were sensitive to UV-C damage, similar to MMR-proficient cells.
- MMR-proficient cells underwent S-G2 arrest and apoptosis after alkylation, while MMR-deficient cells proliferated, with exceptions in some prostate lines.
- Cyclin D1 levels decreased post-alkylation and UV-C damage independently of MMR status, with proteasomal degradation observed in response to alkylation.
Conclusions:
- MMR status dictates tolerance to alkylation damage but not UV-C sensitivity.
- Cyclin D1 downregulation following alkylation damage is an MMR-independent event mediated by proteasomal degradation.
- Cell cycle arrest and apoptosis are differentially regulated by MMR status in response to DNA damage.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair
Mismatch Repair

